Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3074-3078, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Priming with Chlamydia trachomatis Major
Outer Membrane Protein (MOMP) DNA followed by MOMP ISCOM Boosting
Enhances Protection and Is Associated with Increased Immunoglobulin A
and Th1 Cellular Immune Responses
Zhang
Dong-Ji,1
Xi
Yang,1
Caixia
Shen,2
Hong
Lu,2
Andrew
Murdin,3 and
Robert C.
Brunham2,*
Department of Medical Microbiology, Faculty
of Medicine, University of Manitoba, Winnipeg, Manitoba R3E
OW3,1 University of British Columbia
Centre of Disease Control, Vancouver V5Z 4R4,2
and Aventis Pasteur, Toronto, Ontario M2R
3T4,3 Canada
Received 24 January 2000/Returned for modification 10 February
2000/Accepted 15 March 2000
We previously reported that DNA vaccination was able to elicit
cellular immune responses and partial protection against
Chlamydia trachomatis infection. However, DNA immunization
alone did not generate immune responses or protection as great as that
induced by using live organisms. In this study, we evaluated the
immunologic effects of a combinational vaccination approach using
C. trachomatis mouse pneumonitis (MoPn) major outer
membrane protein (MOMP) DNA priming followed by boosting with
immune-stimulating complexes (ISCOM) of MOMP protein (MOMP ISCOM) for
protection of BALB/c mice against MoPn lung infection. Substantially
better protection to challenge infection was observed in mice given
combinational vaccination compared with mice given MOMP ISCOM
immunization alone, and the protection approximated that induced by
live organisms. Enhanced protection was correlated with stronger
delayed-type hypersensitivity, higher levels of gamma interferon
production, and increased immunoglobulin A antibody responses in lung
homogenates. The results indicate that DNA priming followed by ISCOM
protein boosting may be useful in designing a fully protective
chlamydial vaccine.
*
Corresponding author. Mailing address: University of
British Columbia Centre of Disease Control, 2077-655 West 12th,
Vancouver V5Z 4R4, Canada. Phone: (604) 660-1841. Fax: (604) 660-6066. E-mail: robert.brunham{at}bccdc.hnet.bc.ca.
Infection and Immunity, June 2000, p. 3074-3078, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Meoni, E., Faenzi, E., Frigimelica, E., Zedda, L., Skibinski, D., Giovinazzi, S., Bonci, A., Petracca, R., Bartolini, E., Galli, G., Agnusdei, M., Nardelli, F., Buricchi, F., Norais, N., Ferlenghi, I., Donati, M., Cevenini, R., Finco, O., Grandi, G., Grifantini, R.
(2009). CT043, a Protective Antigen That Induces a CD4+ Th1 Response during Chlamydia trachomatis Infection in Mice and Humans. Infect. Immun.
77: 4168-4176
[Abstract]
[Full Text]
-
Kari, L., Whitmire, W. M., Crane, D. D., Reveneau, N., Carlson, J. H., Goheen, M. M., Peterson, E. M., Pal, S., de la Maza, L. M., Caldwell, H. D.
(2009). Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine. J. Immunol.
182: 8063-8070
[Abstract]
[Full Text]
-
Cheng, W., Shivshankar, P., Li, Z., Chen, L., Yeh, I-T., Zhong, G.
(2008). Caspase-1 Contributes to Chlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection. Infect. Immun.
76: 515-522
[Abstract]
[Full Text]
-
Murthy, A. K., Chambers, J. P., Meier, P. A., Zhong, G., Arulanandam, B. P.
(2007). Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of Genital Chlamydia muridarum Infection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon Production. Infect. Immun.
75: 666-676
[Abstract]
[Full Text]
-
Pal, S., Peterson, E. M., de la Maza, L. M.
(2005). Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria. Infect. Immun.
73: 8153-8160
[Abstract]
[Full Text]
-
Pinchuk, I., Starcher, B. C., Livingston, B., Tvninnereim, A., Wu, S., Appella, E., Sidney, J., Sette, A., Wizel, B.
(2005). A CD8+ T Cell Heptaepitope Minigene Vaccine Induces Protective Immunity against Chlamydia pneumoniae. J. Immunol.
174: 5729-5739
[Abstract]
[Full Text]
-
Hechard, C., Grepinet, O., Rodolakis, A.
(2004). Molecular cloning of the Chlamydophila abortus groEL gene and evaluation of its protective efficacy in a murine model by genetic vaccination. J Med Microbiol
53: 861-868
[Abstract]
[Full Text]
-
Hechard, C., Grepinet, O., Rodolakis, A.
(2003). Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice. J Med Microbiol
52: 35-40
[Abstract]
[Full Text]
-
Pal, S., Davis, H. L., Peterson, E. M., de la Maza, L. M.
(2002). Immunization with the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein by Use of CpG Oligodeoxynucleotides as an Adjuvant Induces a Protective Immune Response against an Intranasal Chlamydial Challenge. Infect. Immun.
70: 4812-4817
[Abstract]
[Full Text]
-
Morrison, R. P., Caldwell, H. D.
(2002). Immunity to Murine Chlamydial Genital Infection. Infect. Immun.
70: 2741-2751
[Full Text]
-
Entrican, G, Buxton, D, Longbottom, D
(2001). Chlamydial infection in sheep: immune control versus fetal pathology. JRSM
94: 273-277
[Full Text]
-
Igietseme, J. U., Murdin, A.
(2000). Induction of Protective Immunity against Chlamydia trachomatis Genital Infection by a Vaccine Based on Major Outer Membrane Protein-Lipophilic Immune Response-Stimulating Complexes. Infect. Immun.
68: 6798-6806
[Abstract]
[Full Text]